This inventor holds 3 USPTO granted patents and 2 published patent applications. Top assignee: The University of Texas System. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Heyu Chen: Innovator in Cancer Treatment
Introduction
Heyu Chen is a prominent inventor based in Dallas, TX (US). He has made significant contributions to the field of cancer treatment through his innovative research and development of novel therapies. With a total of 3 patents, Chen is recognized for his groundbreaking work in immunotherapy.
Latest Patents
Chen's latest patents include "Novel LILRB2 Antibodies and Uses Thereof" and "Targeting LILRB4 with CAR-T or CAR-NK Cells in the Treatment of Cancer." These patents reflect his commitment to advancing cancer treatment methodologies and improving patient outcomes.
Career Highlights
Heyu Chen is affiliated with The University of Texas System, where he conducts his research. His work focuses on developing targeted therapies that harness the power of the immune system to combat cancer effectively.
Collaborations
Chen collaborates with esteemed colleagues, including Chengcheng Zhang and Zhiqiang An. These partnerships enhance the scope and impact of his research, fostering innovation in the field.
Conclusion
Heyu Chen's contributions to cancer treatment through his patents and research at The University of Texas System highlight his role as a leading inventor in the medical field. His work continues to inspire advancements in immunotherapy and cancer care.